Correlation Between Madrigal Pharmaceuticals and Sarepta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Sarepta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Sarepta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Sarepta Therapeutics, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Sarepta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Sarepta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Sarepta Therapeutics.
Diversification Opportunities for Madrigal Pharmaceuticals and Sarepta Therapeutics
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Madrigal and Sarepta is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Sarepta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sarepta Therapeutics and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Sarepta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sarepta Therapeutics has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Sarepta Therapeutics go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Sarepta Therapeutics
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 2.33 times more return on investment than Sarepta Therapeutics. However, Madrigal Pharmaceuticals is 2.33 times more volatile than Sarepta Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Sarepta Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 29,341 in Madrigal Pharmaceuticals on October 20, 2024 and sell it today you would earn a total of 23.00 from holding Madrigal Pharmaceuticals or generate 0.08% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. Sarepta Therapeutics
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| Sarepta Therapeutics |
Madrigal Pharmaceuticals and Sarepta Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and Sarepta Therapeutics
The main advantage of trading using opposite Madrigal Pharmaceuticals and Sarepta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Sarepta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sarepta Therapeutics will offset losses from the drop in Sarepta Therapeutics' long position.| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
| Sarepta Therapeutics vs. Krystal Biotech | Sarepta Therapeutics vs. PTC Therapeutics | Sarepta Therapeutics vs. Iovance Biotherapeutics | Sarepta Therapeutics vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |